糖皮质激素的不同给药方法对大鼠骨密度的影响

高泉, 周磊, 高波

高泉, 周磊, 高波. 糖皮质激素的不同给药方法对大鼠骨密度的影响[J]. 实用临床医药杂志, 2012, (5): 4-6. DOI: 10.3969/j.issn.1672-2353.2012.05.002
引用本文: 高泉, 周磊, 高波. 糖皮质激素的不同给药方法对大鼠骨密度的影响[J]. 实用临床医药杂志, 2012, (5): 4-6. DOI: 10.3969/j.issn.1672-2353.2012.05.002
GAO Quan, ZHOU Lei, GAO Bo. Effect of glucocorticoid administration method on bone mineral density in rats[J]. Journal of Clinical Medicine in Practice, 2012, (5): 4-6. DOI: 10.3969/j.issn.1672-2353.2012.05.002
Citation: GAO Quan, ZHOU Lei, GAO Bo. Effect of glucocorticoid administration method on bone mineral density in rats[J]. Journal of Clinical Medicine in Practice, 2012, (5): 4-6. DOI: 10.3969/j.issn.1672-2353.2012.05.002

糖皮质激素的不同给药方法对大鼠骨密度的影响

详细信息
  • 中图分类号: R977.1+1

Effect of glucocorticoid administration method on bone mineral density in rats

  • 摘要: 目的 观察不同的糖皮质激素给药方法对大鼠骨密度的影响.方法 将80只雌性SD大鼠随机分为5组(A、B、C、D、E组),其中A组大鼠作为阴性对照,给予溶剂5 mL/(kg·d)灌胃;B组大鼠给予强的松5mg/(kg·d)灌胃;C组大鼠给予强的松10 mg/(kg·2 d);D组大鼠给予强的松10 mg/(kg·2 d);E组大鼠静脉给予强的松80 mg/(kg·d)×3d,每4周1次,A、B、C、E组观察12周,D组观察24周,分别检测实验前后大鼠椎骨骨密度、血清PTH、血清25羟维生素D3水平.结果 与A组相比,B、C、D组血清PTH水平明显升高,血清25羟维生素D3水平及椎骨骨密度明显下降;E组各项指标的变化无统计学意义.与B组比较,C组大鼠血清PTH水平变化无统计学意义,而血清25羟维生素D3水平及椎骨骨密度的变化有统计学意义,变化程度低于B组;而D组大鼠指标变化程度均大于B组.结论 与每日持续使用糖皮质激素相比较,虽然总量相同,但隔日用药对骨密度的影响较小,而长时间用药对骨密度影响大,而短时间大剂量使用激素,对骨密度的影响则不明显.
  • 邹丽宜, 吴铁. 糖皮质激素与骨质疏松 [J]. 中国骨质疏松杂志, 2003(5):177.
    Vestergaard P, Reinmark L, Mosekilde L. Fracture risk associated with systemic and topical corticosteroids [J]. Internal Medicine, 2005(4):374.
    刘忠厚. 骨质疏松学 [M]. 北京:科学出版社, 1998.645.
    Van everdingen A, Van reesema D R, Jacobsjw. Low-dose glucocorticoids in early rheumatoid arthritis;discordand effects on bone mineral density and fractures [J]. Clinical and Experimental Rheumatology, 2003.155.
    Kelly A, BARTHOLOMEW P, Lapworth A. Peripheralbone density in patients with rheumatoid arthritis and factors which influence it [J]. European J Iinternal Medicine, 2002, (7):423.doi: 10.1016/S0953-6205(02)00129-2.
    Gotzsche P C, Johansen H K. Meta-analysis of short term lowdose prednisolone versus placebo and non-steroidal antiinflmmatorydrugs in rheumatoid arthritis [J]. British Medical Journal, 1998.811.doi: 10.1136/bmj.316.7134.811.
    Kirwan J R. The effect of glucocorticoids on joint destruction in rheumatoid arthritis.The arthritis and rheumatism council low-dose glucocorticoid study group [J]. New England Journal of Medicine, 1995(3):142.doi: 10.1056/NEJM199507203330302.
    Hall G M, Spector T D, Griffin A J. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women [J]. Arthritis and Rheumatism, 1993, (11):1510.doi: 10.1002/art.1780361105.
    Lane N E, Pressman A R, Star V L. Rheumatoid arthritis and bone mineral density in elderly women.The Study of Osteoperotic Fractures Research Group [J]. Journal of Bone and Mineral Research, 1995(2):257.doi: 10.1002/jbmr.5650100212.
计量
  • 文章访问数:  137
  • HTML全文浏览量:  27
  • PDF下载量:  11
  • 被引次数: 0
出版历程
  • 发布日期:  2012-07-23

目录

    /

    返回文章
    返回
    x 关闭 永久关闭